Clinical Trials Browser

Anatomic Stage III Breast Cancer AJCC v8 × abemaciclib × 90 days × Clear all

NCT06179303 2026-02-27

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Phase 2 Recruiting

Anatomic Stage III Breast Cancer AJCC v8